Psychedelic medicines flying high

Three years after Australia’s world-first decision to permit the prescribing of psilocybin and MDMA, other countries are following suit, patient remission rates are in line with international trials, and Big Pharma is well and truly on board, the mental health charity Mind Medicine Australia (MMA) has reported.

To see the whole article please log in.

Simon Webster

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here